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Abstract
Pain is a major symptom associated with chronic inflammation. In previous work from our
laboratory, we have shown that in animal models of neuropathic pain there is a sprouting of
sympathetic fibers into the upper dermis, a territory normally devoid of them. However, it is not
known whether such sympathetic spouting, which is likely trophic factor mediated, also occurs in
chronic inflammation and arthritis. In the present study, we used a rat model of chronic
inflammation in which a small single dose of complete Freund's adjuvant (CFA) was injected
subcutaneously, unilaterally, into the plantar surface of the hindpaw. This led to a localized long-
term skin inflammation and arthritis in all joints of the hindpaw. Animals were perfused with
histological fixatives at 1, 2, 3 or 4 weeks after the injection. Experimental animals treated with CFA
were compared to saline-injected animals. We then investigated the changes in the pattern of
peripheral innervation of the peptidergic nociceptors and sympathetic fibers in rat glabrous
hindpaw skin. Antibodies directed towards calcitonin gene-related peptide (CGRP) and dopamine
beta-hydroxylase (DBH) were used for the staining of peptidergic and sympathetic fibers,
respectively. Immunofluorescence was then used to analyze the different nerve fiber populations
of the upper dermis. At 4 weeks following CFA treatment, DBH-immunoreactive (IR) fibers were
found to sprout into the upper dermis, in a pattern similar to the one we had observed in animals
with a chronic constriction injury of the sciatic nerve in a previous publication. There was also a
significant increase in the density of CGRP-IR fibers in the upper dermis in CFA treated animals at
2, 3 and 4 weeks post-injection. The increased peptidergic fiber innervation and the ectopic
autonomic fibers found in the upper dermis may have a role in the pain-related behavior displayed
by these animals.
Findings
The complete Freund's adjuvant (CFA) model of inflam-
mation of the rat hindpaw has been extensively used as
model of acute and chronic inflammation and arthritis.
When CFA is given subcutaneously at a relatively high
dose, it leads initially to unilateral paw inflammation and
acute arthritis, followed at a later stage by contralateral
paw swelling and a rheumatoid-arthritis like disease, with
multiple joints and organs affected [1-3]. In contrast,
when a low dose of CFA was injected, both the hindpaw
edema and arthritis were strictly unilateral and contralat-
eral signs and systemic disease never appeared [4]. It is
interesting to note that, contrary to the models using a
high dose of CFA, the low dose CFA model has been used
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mostly as an acute or chronic inflammation model (see
e.g. [5,6]). The plastic changes in the spinal dorsal horn
that accompany the peripheral inflammation and arthritis
have been investigated in some detail [6,7]; however, the
changes in the innervation of the skin had not yet been
studied.
In previous work from our laboratory, we have observed a
sprouting into the upper dermis of sympathetic fibers fol-
lowing a chronic constriction injury (CCI) of the sciatic
nerve [8]. The sympathetic fibers were detected in the
upper dermis, a territory from which they are normally
absent, starting at 2 weeks post-lesion and were still
detected at 20 weeks post-lesion. Because nerve growth
factor (NGF) levels in the periphery are known to be
increased after inflammation is induced [9], and NGF is
known to be a trophic factor for the sympathetic fibers
[10], we deemed it important to investigate whether there
would be sympathetic fiber sprouting in CFA-induced
chronic inflammation of the hindpaw.
In the current study, following the subcutaneous injection
of a low dose of CFA in the plantar surface of the hind
paw, there was marked inflammation of the paw, which
was detectable because of redness of the skin and edema,
which were intense at 24 hours post-injection and
remained marked at 30 days (Figure 1). The changes were
strictly unilateral at all time points studied, as the contral-
ateral paws showed no changes (data not shown).
In saline-injected animals (Figures 2A and 2B), and at 1
week post-CFA injection, sympathetic fibers, as detected
by dopamine-β-hydroxylase (DBH) immunoreactivity,
were almost entirely restricted to the lower dermis, and
mostly located around blood vessels. These fibers formed
a mesh around the vessels and displayed numerous small
varicosities separated by rather short non-varicose seg-
ments (Figure 2B). Although occasional DBH-immunore-
active (IR) fibers were found in the upper dermis, their
number was always very low. In CFA-treated animals, at 2,
3 and 4 weeks post-injection some DBH-IR were observed
in the upper dermis, particularly at the 4 week time point,
when their number was significantly higher than in the
saline-injected and CFA-injected at 1 week post-injection
(Figure 3A). These DBH-IR fibers sometimes ended close
to the dermal-epidermal junction (Figures 2C and 2D). In
the upper dermis, the DBH-IR fibers were rarely located
around blood vessels, but were often observed wrapping
around calcitonin gene-related peptide (CGRP)-IR fibers
(Figure 2C, arrows). Also, their varicosities were often
larger than those of similar fibers located in the lower der-
mis (compare Figures 2B and 2C).
Peptidergic nociceptive afferents, as detected by CGRP
immunoreactivity, were observed throughout the skin,
although their density appeared to be higher in the upper
than in the lower dermis (Figure 2). CGRP-IR fibers termi-
nated mostly close or at the dermal-epidermal junction
(Figure 2) but occasionally penetrated the epidermis. No
changes in the CGRP-IR fiber length per unit area were
detected in the CFA-treated animals at the 1-week time
point, when compared to the saline-treated (Figure 3B).
However, we found that there was a significant increase in
total CGRP-IR fiber length at 2, 3 and 4 weeks, when com-
pared to the saline group (Figure 3B). It should be noted,
as described above, that as from 2 weeks post-injection,
these CGRP-IR fibers were sometimes seen wrapping
around the sympathetic fibers in the upper dermis of CFA-
treated animals (Figure 2C), an arrangement almost never
observed in saline-treated animals or contralaterally to the
injection.
Therefore, in this study we detected a sprouting of sympa-
thetic fibers into the upper dermis of the glabrous skin of
the hindpaw at the 4 week time point that was compara-
ble to what we had observed previously in the CCI of the
sciatic nerve neuropathic pain model [8]. To our best
knowledge, this is the first report of sympathetic fiber
sprouting into the inflamed skin. It should be noted that,
as we had observed previously in the glabrous skin of the
hindpaw and hairy skin of the lower lip in two neuro-
pathic pain models, the CCI of the sciatic nerve [8] and
the CCI of the mental nerve [11], the sprouted sympa-
thetic fibers were not associated with blood vessels in the
new territory; they rather wrapped around the peptidergic
nociceptive fibers. Although the density of sympathetic
innervation of the upper dermis that we found in the
inflammation model was much less than what we have
observed in the CCI model at the same 4 week time point
[8], we may be under-estimating the density of fibers in
the upper dermis in the inflammation model. Indeed, we
defined the upper dermis in both inflamed and normal
skin as the region within 150 μm from the dermal-epider-
mal junction, yet in the inflamed skin the overall thick-
ness of the dermis was considerably increased because of
edema and inflammatory cell infiltration. We have made
no attempt to compensate for such difference in thickness.
Contrary to the neuropathic pain models, in which we
had observed a marked reduction in the peptidergic sen-
sory at 2 weeks post-lesion followed by a recovery and
sprouting above sham levels thereafter [8,11], in the
inflammation model we did not detect any decrease in the
density of peptidergic sensory fiber innervation at any
time point. In contrast, as from 2 weeks post-CFA injec-
tion, we observed a significant increase in the density of
the CGRP-IR fiber network, with a maximum at 3 weeks
post-injection. As inflammation and arthritis are known
to increase levels of sensory neuropeptides in the dorsal
root ganglion [12-14], these results are not surprising andMolecular Pain 2008, 4:56 http://www.molecularpain.com/content/4/1/56
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somewhat predictable, although this represents the first
direct anatomical demonstration of increased CGRP-IR
fiber density in inflamed skin. This increased density of
peptidergic fibers may result from a sprouting of fibers
that were already CGRP-IR or from the de novo detection
of CGRP immunoreactivity in fibers in which the peptide
was expressed below detection levels in control animals.
Interestingly, we detected in the CFA inflammation model
the same close appositions between sensory and sympa-
thetic fibers that we had observed in the neuropathic
models [8,11], as shown in Figure 2C. These close associ-
ations have been interpreted by us as a morphological
basis for a direct influence of sympathetic fibers on the
excitability of the sensory fibers through the release of
noradrenaline or other neuroactive chemicals [8].
Although there is no direct evidence that in the presence
of inflammation sensory fibers have acquired sensitivity
to norepinephrine, as it happens in neuropathic pain
models [15], it is possible that they do. In favor of this
possibility, there is evidence in the literature that CFA-
induced inflammation of the L5 spinal nerve leads to
hyperalgesia that is exacerbated by norepinephrine
administration [16]. It should be noted that we have
shown that at the 4 week time point, our animals display
mechanical hyperalgesia [17].
Because we have previously shown that in this model
there is a localized arthritis of all joints of the hindpaw as
from 2 weeks after CFA injection [17], it can be asked
whether the development of arthritis plays a role in the
sympathetic and sensory sprouting we observed, or if it is
only a result of the chronic skin inflammation. To answer
to the above question, a similar study should be per-
formed in a mono-arthritis model involving intra-articu-
lar injection of CFA. However, it should be noted that
there is some indirect evidence that the establishment of
arthritis may play a role. Assuming that NGF plays a major
role in the sprouting, because of the known responsive-
ness of sensory and sympathetic fibers to this neuro-
trophin, it is important to note that it has been shown that
NGF levels in synovial fluid from patients suffering from
rheumatoid arthritis are up to nine times higher than in
control patients [18]. It has also been shown that there is
an acute increase of NGF mRNA within the mast cells
infiltrating the inflamed synovial membrane in adjuvant
induced arthritis in rats and that the levels remain ele-
vated up to two weeks after arthritis has been induced
[19]. Also, one study has shown that levels in the high
affinity NGF receptor, TrkA, in terminals in the spinal cord
in the CFA arthritis model increase after the onset of
arthritis, defined at 12 days post-injection [20].
In conclusion, the sprouting of sympathetic fibers into the
upper dermis and the increased density of peptidergic
afferents in animals with both skin inflammation and
arthritis may play a role in the hyperalgesia in these ani-
mals. It also raises the challenging possibility that a simi-
lar spouting may occur in skin over the inflamed joints in
monoarthritis. However, this possibility needs to be
investigated in future studies. If confirmed, an extremely
interesting similar in changes in skin innervation in neu-
ropathic and arthritis models would be found, and would
provide further evidence that the prevention of nerve fiber
plasticity should be considered as a possible therapeutic
approach to prevent the transition from acute to chronic
pain.
Methods
For each time point, four male Sprague-Dawley rats
weighing 225–250 g (Charles River) were injected with
150 μl of CFA, at a concentration of 1 mg/ml, subcutane-
ously in the plantar surface of the right hind paw. For each
Average maximum width ("diameter"), measured at the level  of the digits, and dorso-ventral thickness of the hindpaw at  several time before and after CFA or saline injection Figure 1
Average maximum width ("diameter"), measured at the level 
of the digits, and dorso-ventral thickness of the hindpaw at 
several time before and after CFA or saline injection. Values 
are expressed as means ± SEM, n = 4. Note that in CFA-
treated animals both parameters are already substantially 
increased and remain elevated at 30 days post-CFA, com-
pared to saline.
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time point, four additional animals were similarly
injected with 150 μl of saline. All animals were sacrificed
7, 14, 21 or 30 days post-injection. All experiments were
approved by the Animal Care Committee of the Faculty of
Medicine at McGill University and were carried out in
accordance with the guidelines of the IASP for pain
research in animals.
Confocal images of the rat's hindpaw skin in saline-treated (A and B) and CFA-treated (C and D) rats, at 30 days post-injection Figure 2
Confocal images of the rat's hindpaw skin in saline-treated (A and B) and CFA-treated (C and D) rats, at 30 days post-injection. 
The material was processed for double immunofluorescence as described in the methods section, and examined with a Zeiss 
LSM 510 confocal microscope. CGRP immunoreactivity is shown in green and DBH immunoreactivity in red. Except for D that 
represents a single optical section, images represent z-stacks projected in the horizontal plane to show an extended focus. In 
A, note that in saline treated rats, the sympathetic fibers (DBH-IR), in red, are not observed in the upper dermis. In B, note 
that in the lower dermis of saline-treated rats sympathetic fibers can be observed in association with an arteriole, which is also 
innervated by CGRP-IR fibers. In contrast, in B and C, which were taken from CFA-treated rats, note the presence of sympa-
thetic fibers in the upper dermis; although in both images they were observed travelling along the dermal-epidermal junction, 
most such fibers did not get as close to the epidermis. In C, note that the sympathetic fibers in the upper dermis often wrap 
around CGRP-IR fibers; arrows show zones of close apposition of the two fiber types (A), although they are detected in the 
lower dermis around blood vessels (B).Molecular Pain 2008, 4:56 http://www.molecularpain.com/content/4/1/56
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Quantitative analysis of sympathetic and sensory fibers in the upper dermis of saline-treated rats and in CFA-treated rats at 1,  2, 3 and 4 weeks post-injection Figure 3
Quantitative analysis of sympathetic and sensory fibers in the upper dermis of saline-treated rats and in CFA-treated rats at 1, 
2, 3 and 4 weeks post-injection. For sympathetic fibers (A), the number of fibers in the upper dermis was counted, whether for 
the sensory fibers the total length of fibers per mm2 was calculated. For details regarding quantification, see Material and Meth-
ods. In A, note that the average number of sympathetic fibers in the upper dermis was higher in the CFA group than in the 
saline group at 2, 3 and 4 weeks post-injection, although that increase reached significance levels at the 4 week time point only. 
One-way ANOVA followed by the Dunnett post hoc test. In B, note that there was a significant difference in the density of the 
sensory peptidergic (CGRP-IR) innervation when comparing saline and CFA-treated groups, starting at 2 weeks-post-CFA 
injection. Statistical analyses were performed by one-way ANOVA followed by the Dunnett post hoc test. Significance was 
established at P < 0.05.
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The maximum mediolateral width (diameter) and maxi-
mum dorso-ventral thickness of the injected paw were
measured before the injection and at 1, 3, 7, 10, 14, 21
and 30 days post-injection. Values were averaged and
expressed as means ± SEM.
For each time point, animals were deeply anesthetized
with Equithesin (6.5 mg chloral hydrate and 3 mg sodium
pentobarbital in a volume of 0.3 ml, i.p., per 100 g body
weight) and then perfused through the left cardiac ventri-
cle with 100 ml of perfusion buffer, followed by 500 ml
of 4% paraformaldehyde (PFA) in 0.1 M phosphate-
buffer (PB), pH 7.4, at room temperature for 30 min. Sub-
sequently, the ipsilateral and contralateral hind paw skin
was collected and postfixed in the same fixative for 1 hour,
at 4°C, after which the specimens were cryoprotected in
30% sucrose in PB overnight at 4°C for later immunocy-
tochemical processing. The skin specimens were taken
from the glabrous skin located between the tori, where
mechanical allodynia testing is commonly performed.
Special care was taken to avoid the base of the tori,
because the innervation of this region is atypically dense.
Tissue was then embedded in an optimum cutting tem-
perature medium (OCT) compound (TissueTek). Fifty-
μm-thick sections were cut at -20°C on a cryostat (Leica)
and collected into phosphate-buffered saline (PBS). Sub-
sequently, the sections were placed in 50% ethanol for 30
minutes and washed for an additional 30 minutes in
phosphate buffered saline plus 0.2% Triton X-100
(PBS+T). The sections were then placed in 1% sodium
borohydride in PBS followed by multiple washes in PBS
for a total of 60 minute. Subsequently, the sections were
incubated in 10% normal goat serum (NGS: Sigma) to
prevent non-specific binding of secondary antibodies. For
each hindpaw, a minimum of 6 sections were processed
per immunostaining. The tissue was then incubated for 48
hours at 4°C in one of the primary antibodies. These were
an anti-calcitonin gene-related peptide (CGRP) antibody
(1:2000; product number C8198, lot 013K4842 Sigma),
raised in rabbit, and a mouse monoclonal anti-DBH
(clone DBH 41; spent tissue culture supernatant diluted
1:5; gift of Dr. A. Claudio Cuello; [21]). After 48 hours, the
sections were washed for 30 minutes with PBS + T and
then placed in a solution containing either Alexa Fluor
488-conjugated goat anti-rabbit IgG (1:400; Molecular
Probes) or highly cross-adsorbed goat anti-mouse IgG
conjugated to Alexa Fluor 594 (1:800; Molecular Probes)
and 10% NGS, for 2 hours at room temperature. All sec-
tions were then washed for 20 minutes with PBS and
mounted and coverslipped with Aquapolymount (Poly-
sciences). A few sections from each animal were processed
for double-labeling of CGRP and DBH. For that, some sec-
tions were processed in a mixture of the two primary anti-
bodies, washed, and then incubated in a mixture of the
secondary antibodies. All other steps were performed as
described above. These double-labeled sections were used
only for qualitative analyses and for illustrations.
The slides were then stored protected from light at 4°C
until examined by conventional fluorescence and confo-
cal microscopy. In this study, as in previous work from
our laboratory, we have divided the dermis into upper
and lower dermis. We have defined the upper dermis as
the area of the dermis spanning 150 μm below the der-
mal-epidermal junction [8]. This represents the area of the
dermis from which sympathetic fibers are normally
absent [8]. Quantitative analyses were performed on sec-
tions of skin from the hindpaw ipsilateral to the CFA or
saline injection. All the material used for quantification
was single-labeled for either CGRP or DBH. For the meas-
urement of the density of the CGRP-immunoreactive (-IR)
innervation, digital images were obtained using the Zeiss
Axioplan 2 imaging fluorescence microscope equipped
with a motorized stage and focus as well as a ×40 oil-
immersion Plan-Fluotar objective and a Zeiss Axiocam
high resolution color digital camera. The camera was con-
nected to a Windows-based computer running the Zeiss
Axiovision 4.5 software. Per animal, series of images from
six randomly selected fields in the upper dermis were
taken along the Z-axis for each of 3 sections, for a total of
18 image sets per animal. These image sets were merged
into a single Extended Focus image using the Axiovision
software. Therefore, all the fibers present in the entire
thickness of the section were observed in focus. Because
there was little fiber overlap along the Z-axis, the quality
was comparable to that obtained with confocal z-axis
stacks, and allowed us to measure the density of the fibers
projected into the horizontal plane. Images were exported
in the TIFF format to be analyzed by a MCID Elite image
analysis system (Imaging and Research, St. Catherines,
Ontario, Canada). By use of a tracing tool, the region in
each image corresponding to the upper dermis was out-
lined. The image analysis software automatically detected
the fibers and reduced then to one pixel in thickness to
calculate fiber density, which is expressed as total fiber
length (μm) per scan area (μm2). To test for significance,
the mean density of fibers in the upper dermis of treated
animals was compared to saline-injected animals using
one-way ANOVA between all time points and pairwise
comparisons were assessed using the Dunnett post hoc test.
As no significant difference was detected among the con-
trol groups of all time points, they were pooled. Sympa-
thetic nerve fiber density was determined by counting the
number of DBH-IR fibers in the upper dermis with the
Zeiss Axioplan 2 microscope using the ×40 oil-immersion
objective. For that, we used 6 skin sections per animal. In
each section, the entire region corresponding to the upper
dermis was scanned and all DBH-IR fibers counted and
photographed. For each individual fiber the distance from
the extremity of the fiber to the dermal-epidermal junc-Molecular Pain 2008, 4:56 http://www.molecularpain.com/content/4/1/56
Page 7 of 7
(page number not for citation purposes)
tion was measured with the software; if such distance was
of less than 150 μm, the fibers were considered as being in
the upper dermis. In each section, the total area analyzed
was calculated by multiplying the total length of the sec-
tion by the upper dermis thickness (150 μm). Compari-
sons among the CFA-injected animals of all time points
and the saline group were performed by means of one-
way ANOVA and pairwise comparisons were assessed
using the Dunnett post hoc test. As there were no signifi-
cant differences among values from the saline-injected
rats of all time points, they were pooled. In all statistical
analyses, significance was set at p < 0.05.
The illustrations were prepared from confocal microscopy
Z-stacks projected into the horizontal plane. For that, sec-
tions were examined with a Zeiss LSM 510 confocal scan-
ning laser microscope (Carl Zeiss Canada, Kirkland, QC,
Canada) with Argon and Helium-Neon lasers and appro-
priate filter sets for separate detection of Alexa Fluor 488
and Alexa Fluor 594, using a multi-track approach. The
images were optimized for brightness and contrast using
Adobe Photoshop version 7. Graphics were prepared with
GraphPad Prism version 5.
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